MedTrace Logo

Arabic PRO Measures for Head and Neck Cancer Radiotherapy.

NCT06662929 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2024-10-29

No results posted yet for this study

Summary

The goal of Arabic patient-reported outcome measures during radiotherapy for head and neck cancer is to test the patient-reported outcome measure (PROM) tools. PROM tools are not validated cross-culturally in Arabic-speaking patient populations, which limits their use in our clinical setting. Validation of these PROM tools will allow clinicians to identify the concerns related to our patient population and measure the outcome of our interventions. Main objectives are:

* To further validate (cross-culture) the PROM instruments related to head and neck cancer (HNC) in Arabic patients.
* To investigate the prevalence and severity of the patient-reported concerns and their relevance with demographics and clinical characteristics.

The participants will be given tasks to complete 6 tools survey before, during, and after radiotherapy.

Conditions

Interventions

RADIATION

Radiation

Radiotherapy for the Head \& Neck Cancer

Sponsors & Collaborators

  • King Saud University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2025-06-01
Completion
2025-10-01

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06662929 on ClinicalTrials.gov